Relative freedom from harm, a term which, in clinical trials, refers to an absence of harmful side effects resulting from use of the product under investigation; it may be assessed by laboratory testing of biological samples, special tests and procedures, psychiatric evaluation, and/or physical examination of subjects/patients.